United States · FDA National Drug Code directory
palonosetron hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69097-927_04460041-adec-463b-ba9d-6a12038ab672
- Product NDC
- 69097-927
- Form
- INJECTION
- Composition / generic term
- palonosetron hydrochloride
- Labeler
- Cipla USA Inc.
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start / end (source format)
- 20180323
- Source listing expiry
- 20261231
Source-listed ingredients
- PALONOSETRON HYDROCHLORIDE — .25 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (69097-927-35) / 5 mL in 1 VIAL · 69097-927-35
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →